These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7869057)

  • 21. Papillary adenocarcinoma in situ of bladder.
    O'Brien AM; Urbanski SJ
    J Urol; 1985 Sep; 134(3):544-6. PubMed ID: 4032558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [ALA fluorescent diagnosis of bladder cancer].
    Al'-Shukri SKh; Danil'chenko DI; Kënig F; Shnorr D
    Urologiia; 2000; (5):48-50. PubMed ID: 11392226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. AgNORs in benign, borderline and transitional cell neoplasms of the urinary bladder.
    Misra V; Mukherjee J; Gupta SC; Tandon S; Gupta AK
    APMIS; 1998 Oct; 106(10):987-92. PubMed ID: 9833702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin.
    D'Hallewin MA; De Witte PA; Waelkens E; Merlevede W; Baert L
    J Urol; 2000 Aug; 164(2):349-51. PubMed ID: 10893582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outpatient diagnostic of bladder tumours in flexible cystoscopes: evaluation of fluorescence-guided flexible cystoscopy and bladder biopsies.
    Hermann GG; Mogensen K; Toft BG; Glenthøj A; Pedersen HM
    Scand J Urol Nephrol; 2012 Feb; 46(1):31-6. PubMed ID: 22150596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Fluorescence diagnosis of porphyrin-marked urothelial tumors. Status of experimental development].
    Jocham D; Baumgartner R; Fuchs N; Lenz H; Stepp H; Unsöld E
    Urologe A; 1989 Mar; 28(2):59-64. PubMed ID: 2718294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Routine bladder biopsy after bacille Calmette-Guérin treatment: is it necessary?
    Skemp NM; Fernandes ET
    Urology; 2002 Feb; 59(2):224-6. PubMed ID: 11834390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Studies on contact-micro-cystoscopy. I. Observation of the bladder epithelium with the contact-micro-colpohysteroscope].
    Nakao M; Mishina T; Kobayashi T; Maegawa M; Nakagawa S; Toyoda K; Watanabe H
    Nihon Hinyokika Gakkai Zasshi; 1985 Apr; 76(4):516-20. PubMed ID: 4032912
    [No Abstract]   [Full Text] [Related]  

  • 29. [Dysplasias and carcinomas in situ of the urothelium].
    Mihatsch MJ
    Helv Chir Acta; 1985 Sep; 52(3-4):435-46. PubMed ID: 4066371
    [No Abstract]   [Full Text] [Related]  

  • 30. Prostatic biopsy in selected patients with carcinoma in situ of the bladder: preliminary report.
    Grabstald H
    J Urol; 1984 Dec; 132(6):1117-8. PubMed ID: 6502798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coexistence of papillary and nodular carcinomas in the urinary bladder.
    Kakizoe T; Matsumoto K; Tobisu K; Takai K; Teshima S; Kishi K
    Jpn J Clin Oncol; 1987 Jun; 17(2):179-86. PubMed ID: 3613141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive papillary carcinoma of the bladder associated with carcinoma in situ.
    Althausen AF; Prout GR; Daly JJ
    J Urol; 1976 Nov; 116(5):575-80. PubMed ID: 978809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spectroscopic diagnosis of bladder cancer with elastic light scattering.
    Mourant JR; Bigio IJ; Boyer J; Conn RL; Johnson T; Shimada T
    Lasers Surg Med; 1995; 17(4):350-7. PubMed ID: 8684237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fluorescent endoscopy superior to white light endoscopy. Detecting cancers of the urinary bladder earlier].
    Zaak D
    MMW Fortschr Med; 2002 Mar; 144(13):24-6. PubMed ID: 12001582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical significance of denuded urothelium in bladder biopsy.
    Levi AW; Potter SR; Schoenberg MP; Epstein JI
    J Urol; 2001 Aug; 166(2):457-60. PubMed ID: 11458047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outpatient biopsy of bladder and urethra performed under topical anesthesia.
    McAninch JW; Kiesling VJ; Beck PN
    Mil Med; 1982 Aug; 147(8):655-9. PubMed ID: 6817210
    [No Abstract]   [Full Text] [Related]  

  • 37. Are cystoscopy and urinary cytology sufficient to identify candidates for subsequent biopsy after bacillus Calmette-Guérin treatment in patients with bladder carcinoma in situ?
    Haase RN; Harving N
    Scand J Urol; 2015; 49(4):338-40. PubMed ID: 25660358
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnosis and substaging of pT1 bladder cancer].
    Cheng L; Huang WB; Zheng SQ; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):636-9. PubMed ID: 18070458
    [No Abstract]   [Full Text] [Related]  

  • 39. [Value of exfoliative cytology of the urinary bladder in occult bladder cancer and in the control of treated cancers].
    Schmitz A; Meyer U; Kierfeld G; Küchemann K
    Urologe A; 1984 Sep; 23(5):278-80. PubMed ID: 6542269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is fluorescent cystoscopy of cost/benefit/therapeutic value for carcinoma in situ of the bladder? No (a difficult task).
    O'Brien T
    J Urol; 2013 Jul; 190(1):20-1. PubMed ID: 23602484
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.